Onkure Therapeutics, Stock Today
| OKUR Stock | 5.00 0.09 1.83% |
PerformanceVery Weak
| Odds Of DistressAverage
|
OnKure Therapeutics, is selling at 5.00 as of the 21st of March 2025; that is 1.83% up since the beginning of the trading day. The stock's lowest day price was 4.91. OnKure Therapeutics, has 54 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. OnKure Therapeutics, symbol was changed from RPHM on 7th of October 2024. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
IPO Date 7th of October 2024 | Category Healthcare |
OnKure Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 12.65 M outstanding shares of which 1.1 M shares are now shorted by private and institutional investors with about 10.28 trading days to cover. More on OnKure Therapeutics,
Moving together with OnKure Stock
Moving against OnKure Stock
OnKure Stock Highlights
| Older Symbol | RPHM |
| CEO President | Nicholas Saccomano |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) |
| Average Analyst Recommendation | |
OnKure Therapeutics, (OKUR) is traded on NASDAQ Exchange in USA. It is located in 6707 Winchester Circle, Boulder, CO, United States, 80301 and employs 46 people. OnKure Therapeutics, was previously known as RPHM Old and was traded on NASDAQ Exchange under the symbol RPHM. OnKure Therapeutics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 76.57 M. OnKure Therapeutics, conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 12.65 M outstanding shares of which 1.1 M shares are now shorted by private and institutional investors with about 10.28 trading days to cover.
OnKure Therapeutics, generates negative cash flow from operations
Check OnKure Therapeutics, Probability Of Bankruptcy
Ownership AllocationThe market capitalization of OnKure Therapeutics, is USD76.57 Million. The majority of OnKure Therapeutics, outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in OnKure Therapeutics, to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in OnKure Therapeutics,. Please pay attention to any change in the institutional holdings of OnKure Therapeutics, as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check OnKure Ownership Details
OnKure Therapeutics, Historical Income Statement
OnKure Stock Against Markets
OnKure Therapeutics, Corporate Management
| Kevin Litwiler | Senior Pharmacology | Profile | |
| Jason CPA | Chief Officer | Profile | |
| Pr Liu | Member Board | Profile | |
| Rogan JD | General Secretary | Profile | |
| Roberta Alton | Senior Operations | Profile | |
| Dylan Hartley | Chief Officer | Profile |
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.